Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling
- DOI
- 10.3390/medicina62091802
- Published
- 09
- Container
- Medicina
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/medicina62091802,
title = {Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling},
author = {Richard Dahma and Elena-Alina Moacă and Iasmina-Alexandra Predescu and Ana-Cristiane Dragomir and Oana-Andrada Iftode and Stela Iurciuc and Diana Haj Ali and Ioana Macaşoi and Maria Sala-Cîrtog and Iulia-Najette Crintea and Alina-Doina Tănase and Marilena Dinuţi},
year = {2026},
journal = {Medicina},
doi = {10.3390/medicina62091802},
url = {https://doi.org/10.3390/medicina62091802}
}RIS
TY - JOUR TI - Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling AU - Richard Dahma AU - Elena-Alina Moacă AU - Iasmina-Alexandra Predescu AU - Ana-Cristiane Dragomir AU - Oana-Andrada Iftode AU - Stela Iurciuc AU - Diana Haj Ali AU - Ioana Macaşoi AU - Maria Sala-Cîrtog AU - Iulia-Najette Crintea AU - Alina-Doina Tănase AU - Marilena Dinuţi PY - 2026 JO - Medicina DO - 10.3390/medicina62091802 UR - https://doi.org/10.3390/medicina62091802 ER -
APA
Dahma, R., Moacă, E., Predescu, I., Dragomir, A., Iftode, O., Iurciuc, S., Ali, D. H., Macaşoi, I., Sala-Cîrtog, M., Crintea, I., Tănase, A., & Dinuţi, M. (2026). Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling. Medicina. https://doi.org/10.3390/medicina62091802
Source records
- doaj · retrieved 2026-09-26T14:57:16.695Z